LifeVantage (NASDAQ:LFVN) Stock Passes Above 200 Day Moving Average – Here’s What Happened

LifeVantage Co. (NASDAQ:LFVN)’s share price passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $7.82 and traded as high as $12.76. LifeVantage shares last traded at $12.30, with a volume of 91,453 shares changing hands.

LifeVantage Price Performance

The firm has a market capitalization of $150.38 million, a PE ratio of 42.29 and a beta of 0.84. The company’s fifty day simple moving average is $9.92 and its 200 day simple moving average is $7.89.

LifeVantage (NASDAQ:LFVN) last announced its quarterly earnings results on Wednesday, August 28th. The company reported $0.14 EPS for the quarter, missing analysts’ consensus estimates of $0.21 by ($0.07). The business had revenue of $48.93 million for the quarter. LifeVantage had a net margin of 1.47% and a return on equity of 27.85%.

LifeVantage Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 17th. Stockholders of record on Monday, September 9th were issued a $0.04 dividend. This represents a $0.16 dividend on an annualized basis and a dividend yield of 1.35%. The ex-dividend date of this dividend was Monday, September 9th. LifeVantage’s payout ratio is currently 57.14%.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in the stock. Ritholtz Wealth Management grew its stake in LifeVantage by 62.0% during the third quarter. Ritholtz Wealth Management now owns 28,666 shares of the company’s stock valued at $346,000 after acquiring an additional 10,974 shares in the last quarter. Renaissance Technologies LLC raised its position in shares of LifeVantage by 2.1% in the second quarter. Renaissance Technologies LLC now owns 855,118 shares of the company’s stock worth $5,490,000 after buying an additional 17,300 shares in the last quarter. Hantz Financial Services Inc. purchased a new stake in shares of LifeVantage in the second quarter worth $91,000. Hillsdale Investment Management Inc. bought a new stake in LifeVantage during the first quarter valued at $76,000. Finally, Acadian Asset Management LLC grew its position in LifeVantage by 2.8% during the first quarter. Acadian Asset Management LLC now owns 228,088 shares of the company’s stock worth $1,378,000 after buying an additional 6,121 shares in the last quarter. Hedge funds and other institutional investors own 35.32% of the company’s stock.

LifeVantage Company Profile

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.